Matthew A. Spear - Sep 9, 2021 Form 4 Insider Report for Poseida Therapeutics, Inc. (PSTX)

Role
Chief Medical Officer
Signature
/s/ Harry J. Leonhardt, Attorney-in-Fact
Stock symbol
PSTX
Transactions as of
Sep 9, 2021
Transactions value $
$13,220
Form type
4
Date filed
9/10/2021, 04:19 PM
Previous filing
Aug 24, 2021
Next filing
Dec 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PSTX Common Stock Options Exercise $13.2K +10K +24.11% $1.32 51.5K Sep 9, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PSTX Stock Option (Right to Buy) Options Exercise $0 -10K -11.01% $0.00 80.9K Sep 9, 2021 Common Stock 10K $1.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is fully vested and exercisable.